The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
With flu and COVID hospital admission rates now mirroring each other, Novavax, which lost out in the COVID vaccine race to Pfizer and Moderna, signed a licensing agreement with Sanofi to commercialize a combined COVID-flu shot.